Table 3: Side effect among studied group.

Parameters

SOF+ DAC (n= 95)

SOF+DAC+RBV (n= 32)

Patient with any adverse effect

19 (20,0%)

3 (9,4%)

Patient with a serious adverse effect

0 (0%)

4 (12%)

Death

0 (0%)

0 (0%)

Anorexia

6 (6,3%)

5 (15,6%)

Fatigue

19 (20,0%)

7 (21,9%)

Fever

9 (9,5%)

3 (9,4%)

Insomnia

8 (8,4%)

3 (9,4%)

Headache

16 (16,8%)

3 (9,4%)

Dizziness

16 (16,8%)

1 (3,1%)

Decreased hemoglobin (<10 g/dL)

2 (2,1%)

7 (21,9%)

Increased serum bilirubin

6 (6,3%)

30 (93,8%)